Melanie Lendnal, Senior Vice President, Policy & Advocacy

“Emerging insights from immunology are reshaping how we understand ALS and where new treatments may come from. This measure is a critical step toward accelerating research that can meaningfully slow disease progression. For people living with ALS, time is the one thing they don’t have, making action like this not just important, but imperative.”